Abstract
Receptor tyrosine kinases (RTKs) are cell surface receptors that transmit extracellular signals to the interior of the cell activating multiple signaling cascades: the binding of specific extracellular ligands activates RTKs which act as a scaffold at plasma membrane level for the recruitment and activation of several signaling molecules. A paradigm shift emerged when an alternative direct signaling pathway was discovered: RTKs may move from cell surface to nucleus where they transduce the signals in a direct way. More recently, evidence has accumulated that RTKs may also translocate to mitochondria and regulate their functions, i.e., by altering tyrosine phosphorylation of specific mitochondrial proteins. This latter emerging pathway is here reviewed and discussed.
Keywords: EGFR, ErbB-2, FGFR-1, FLT-3, mitochondria, neurotrophin receptors, tyrosine kinase receptors, tyrosine phosphorylation.
Current Protein & Peptide Science
Title:Receptor Tyrosine Kinases Take a Direct Route to Mitochondria: An Overview
Volume: 14 Issue: 7
Author(s): Mauro Salvi
Affiliation:
Keywords: EGFR, ErbB-2, FGFR-1, FLT-3, mitochondria, neurotrophin receptors, tyrosine kinase receptors, tyrosine phosphorylation.
Abstract: Receptor tyrosine kinases (RTKs) are cell surface receptors that transmit extracellular signals to the interior of the cell activating multiple signaling cascades: the binding of specific extracellular ligands activates RTKs which act as a scaffold at plasma membrane level for the recruitment and activation of several signaling molecules. A paradigm shift emerged when an alternative direct signaling pathway was discovered: RTKs may move from cell surface to nucleus where they transduce the signals in a direct way. More recently, evidence has accumulated that RTKs may also translocate to mitochondria and regulate their functions, i.e., by altering tyrosine phosphorylation of specific mitochondrial proteins. This latter emerging pathway is here reviewed and discussed.
Export Options
About this article
Cite this article as:
Salvi Mauro, Receptor Tyrosine Kinases Take a Direct Route to Mitochondria: An Overview, Current Protein & Peptide Science 2013; 14 (7) . https://dx.doi.org/10.2174/13892037113146660087
DOI https://dx.doi.org/10.2174/13892037113146660087 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Gene Sets of Gene Ontology are More Stable Diagnostic Biomarkers than Genes in Oral Squamous Cell Carcinoma
Current Bioinformatics Role of Genetic Factors in Statins Side-Effects
Cardiovascular & Hematological Disorders-Drug Targets Tyrosine Kinase Inhibitors
Current Cancer Drug Targets Metabotropic Glutamate Receptor Ligands as Potential Therapeutics for Addiction
Current Drug Abuse Reviews Anticancer Advances of Matrine and Its Derivatives
Current Pharmaceutical Design Contrast Functions of αA- and αB-Crystallins in Cancer Development
Current Molecular Medicine A Simple, Efficient and Environmentally Benign Synthetic Protocol for the Synthesis of Spirooxindoles Using Choline Chloride-Oxalic Acid Eutectic Mixture as Catalyst/Solvent System
Combinatorial Chemistry & High Throughput Screening The Medicinal Chemistry of Therapeutic Peptides: Recent Developments in Synthesis and Design Optimizations
Current Medicinal Chemistry Pharmacological Activation of p53 in Cancer Cells
Current Pharmaceutical Design Discovery of Hedgehog Antagonists for Cancer Therapy
Current Medicinal Chemistry Adenovirus Vectors Composed of Subgroup B Adenoviruses
Current Gene Therapy Specific Targeting of Akt Kinase Isoforms: Taking the Precise Path for Prevention and Treatment of Cancer
Current Drug Targets Clinical Experiment of Mutant Herpes Simplex Virus HF10 Therapy for Cancer
Current Cancer Drug Targets Anionic Host Defence Peptides from the Plant Kingdom: Their Anticancer Activity and Mechanisms of Action
Protein & Peptide Letters Design of Telomerase Inhibitors for the Treatment of Cancer
Current Pharmaceutical Design Clinical and <i>In Silico</i> Outcomes of the Expression of miR-130a-5p and miR-615-3p in Tumor Compared with Non-Tumor Adjacent Tissues of Patients with BC
Anti-Cancer Agents in Medicinal Chemistry Application of Machine Learning in Animal Disease Analysis and Prediction
Current Bioinformatics Current and Future Therapeutic Targets: A Review on Treating Head and Neck Squamous Cell Carcinoma
Current Cancer Drug Targets Recent Advances in the Structure-Based and Ligand-Based Design of IKKβ Inhibitors as Anti-inflammation and Anti-cancer Agents
Current Medicinal Chemistry PET Imaging of the Peripheral Benzodiazepine Receptor: Monitoring Disease Progression and Therapy Response in Neurodegenerative Disorders
Current Pharmaceutical Design